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Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months 
following cessation of exercise supervision in nonalcoholic fatty liver disease 
CJA Pugh1, VS Sprung2,3, H Jones4, P Richardson5, F Shojaee-Moradie6, AM Umpleby6, DJ Green4,7, NT 
Cable4,8, MI Trenell9, 
GJ Kemp2,10 and DJ Cuthbertson2,3 
Supervised exercise reduces liver fat and improves endothelial function, a surrogate of 
cardiovascular disease (CVD) risk, in nonalcoholic fatty liver disease (NAFLD). We hypothesised that 
after a 16-week supervised exercise program, patients would maintain longer-term improvements in 
cardiorespiratory ﬁtness, liver fat and endothelial function. Ten NAFLD patients (5/5 males/females, 
age 51 ± 13 years, body mass index 31 ± 3 kg m− 2 (mean ± s.d.)) underwent a 16-week supervised 
moderate-intensity exercise intervention. Biochemical markers, cardiorespiratory ﬁtness (VO2peak), 
subcutaneous, visceral and liver fat (measured by magnetic resonance imaging and spectroscopy 
respectively) and brachial artery ﬂow-mediated dilation (FMD) were assessed at baseline, after 16 
weeks of supervised training and 12 months after ending supervision. Despite no signiﬁcant change 
in body weight, there were signiﬁcant improvements in VO2peak (6.5 ml kg − 1 min − 1 (95% 
conﬁdence interval 2.8, 10.1); P = 0.003), FMD (2.9% (1.5, 4.2); P = 0.001), liver transaminases 
(Po0.05) and liver fat (−10.1% (−20.6, 0.5); P = 0.048) immediately after the 16-week supervised 
training. Nevertheless, 12 months after ending supervision, VO2peak (0.9 ml kg − 1 min − 1 (−3.3, 
5.1); P = 0.65), FMD (−0.07% (−2.3, 2.2); P = 0.95), liver transaminases (P40.05) and liver fat (1.4% 
(−13.0, 15.9); P = 0.83) were not signiﬁcantly different from baseline. At 12 months following 
cessation of supervision, exercise-mediated improvements in liver fat and other cardiometabolic 
variables had reversed with cardiorespiratory ﬁtness at baseline levels. Maintenance of high 
cardiorespiratory ﬁtness and stability of body weight are critical public health considerations for the 
treatment of NAFLD (Clinicaltrials.gov identiﬁer: NCT01834300). 
INTRODUCTION 
Nonalcoholic fatty liver disease (NAFLD) increases liver-related morbidity and mortality,1 yet 
cardiovascular disease (CVD) is the leading cause of its mortality.2 We need effective sustainable 
interventions to reverse NAFLD and reduce cardiovascular risk. In the absence of approved 
pharmacological treatment, structured exercise and/or dietary modiﬁcation are recommended as 
ﬁrst-line treatment in NAFLD.3 The cardiometabolic beneﬁts of supervised exercise, which include 
reduced liver fat, enhanced peripheral insulin sensitivity and microvascular and conduit artery 
endothe-lial function,4,5 do not require weight loss. Parallel improvements in liver fat and cardiac 
structure and function6 emphasise the role of exercise as an intervention to reduce both hepatic 
and CVD risk. 
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We hypothesised that after a 16-week supervised exercise program, patients would maintain the 
longer-term improvements in cardiorespiratory ﬁtness, liver fat and endothelial function. To test, 
this we re-examined a subset of previously reported patients 4,5 12 months after ending exercise 
supervision. 
MATERIALS AND METHODS 
At baseline, NAFLD was diagnosed by a hepatologist based on raised transaminases (after exclusion 
of secondary causes) with conﬁrmation of elevated liver fat (⩾5.5%) by proton magnetic resonance 
spectroscopy. All participants were physically inactive (<2 h per week of low-intensity physical 
activity), normotensive, normoglycaemic, non-smoking Caucasians, with no history of excessive 
alcohol intake (males <21 and females <14 units per week) or any contraindications to exercise; 
females were post-menopausal. 
Patients who completed a 16-week structured and supervised exercise intervention were offered 
the opportunity to repeat assessments 12 months later. From the original study cohort, 10 patients 
who completed the exercise intervention4,5 (5 males and 5 females; 51 ± 13 years; body mass index 
31 ± 3 kg m− 2) under-went repeat assessments 12 months later. All participants remained with 
similar alcohol intake and as normotensive, normoglycaemic, nonsmokers. Liverpool Central 
Research Ethics Committee approved the study, and all participants gave written informed consent. 
Measurements were performed fasted at baseline, after 16 weeks of supervised exercise training 
and 12 months after its end.5 Anthropo-metric measurements were taken and blood samples 
collected for plasma glucose, lipid proﬁles and liver enzymes. 
Magnetic resonance scanning at 1.5T was performed as previously described.5 Abdominal visceral 
(VAT) and subcutaneous adipose tissue (SAT) were calculated from whole-body axial T1-weighted 
fast spin echo scans. Total abdominal adipose tissue (AT) = VAT+SAT. Liver fat was measured using 
proton magnetic resonance spectroscopy and expressed as % CH2 lipid amplitude relative to water 
signal. 
 Figure 1. Changes in (a) cardiorespiratory ﬁtness (VO2peak), (b) body weight (c) liver fat (%), and (d) ﬂow-mediated dilation 
FMD (%) at baseline (‘Pre-ex’), following 16 weeks of supervised exercise training (‘Post-ex’) and 12 months following 
cessation of exercise supervision (‘1 year’). Data are presented as mean (95% CI) and as individual patient values. 
†Signiﬁcantly different from baseline (P<0.05). ‡Signiﬁcantly different from immediately following 16 weeks of supervised 
exercise training (P<0.05). 
 
High-resolution ultrasound (Terason, t3000, Aloka, Burlington, MA, USA) was used to image the 
brachial artery after 30 min of supine rest. Endothelial-dependent function was assessed as ﬂow-
mediated dilation (FMD): brachial artery diameter, ﬂow and shear stress were measured before and 
after 5 min of forearm cuff inﬂation, and FMD was calculated as peak artery diameter following 
hyperaemia, expressed as % increase using an allometric model. Endothelium-independent function 
was assessed by imaging 1 min before and 10 min after sublingual (400 μg) glyceryl trinitrate.7 
Cardiorespiratory ﬁtness (5) was assessed on a treadmill erg-ometer, initially 2.7 km h − 1 at 5° 
gradient, with step-wise increments every 1 min. VO2peak was calculated from expired gas (Oxycon 
Pro, Jaegar, Hoechberg, Germany) as the highest consecutive 15 s period of oxygen uptake in the last 
min before exhaustion. No self-reported or objective assessment of physical activity and/or exercise 
was made following the cessation the 16-week structured exercise intervention. 
For the exercise training intervention, an exercise physiologist provided supervision and guidance. 
Based upon individual basal ﬁtness, participants underwent 30 min of moderate-intensity aerobic 
exercise 3 times/week at 30% heart rate reserve (HRR), progressing weekly based on HR responses 
in the initial 4 weeks. Intensity increased to 45% HRR for the following 4 weeks, until week 8, where 
HRR remained at 45% but each session increased to 45 min. From week 12, participants were 
exercising 5 times/week for 45 min at 60% HRR. Upon completion of the supervised exercise, 
patients had no contact from the research team for 12 months. 
A general linear model with repeated measures was employed to evaluate differences between 
baseline, immediate and 12-month post-training data. Analyses were performed using SPSS 21.0 
(SPSS, Chicago, IL, USA). All data in the text, ﬁgure and table, including changes, are presented as 
mean (95% conﬁdence intervals), except age and body mass index (presented as mean and s.d.). 
Intraobserver coefﬁcients of variation for measurements of liver fat and FMD were 6.0(ref. 8) and 
6.7%,9 respectively. 
RESULTS 
Body weight did not change signiﬁcantly from baseline over the training period (change = − 1.9 kg 
(−1.5, 5.2); P = 0.29), or 12 months following its completion (−0.2 kg, (−3.6, 3.1); P = 0.90; Figure 1). 
VO2peak increased (6.5 ml kg − 1 min − 1 (2.8, 10.1); P = 0.003) and waist circumference decreased 
(−6 cm (−9, − ); P = 0.004) following training, but had returned to baseline 12 months later (0.9 ml kg 
− 1 min − 1 (−3.3, 5.1); P =0.67 (Figure 1) and − 1 cm (−7, 5); P =0.60 (Table 1), respectively). 
Liver fat (−10.1% (−20.6, 0.5); P = 0.048), alanine aminotransferase (−20 U l − 1 (−41, 1); P = 0.05) and 
aspartate aminotransferase (−11 U l − 1 (−21, − 1); P = 0.04) decreased following training but had 
returned to baseline 12 months later (1.4% (−13.0, 15.9); P =0.83); Figure 1; 10 U l− 1 (−21, 41); P = 
0.48 & 2 U l − 1 (−11, 16); P = 0.70; Table 1 respectively). There were no signiﬁcant changes in VAT, 
SAT or total AT (P40.20; Table 1). 
FMD improved (2.9% (1.5, 4.2); P = 0.001) following training, but had returned to baseline 12 months 
later (−0.07% (−2.3, 2.2); P =0.95; Figure 1). There were no signiﬁcant differences in endothelium-
independent (glyceryl trinitrate mediated) dilation (P = 0.74; Table 1). 
 Patients who lost the most weight during the 16-week intervention period had the smallest gain in 
liver fat between weeks 16 and 68 (P = 0.03); 1 kg reduction in body weight at 16 weeks reduced the 
change in liver fat by ~ 4.5% in the following 52-week period. 
CONCLUSION 
Longitudinal data suggest that although vigorous physical activity can prevent liver fat accumulation, 
adherence to current national and international physical activity guidelines alone is not sufﬁcient to 
prevent NAFLD.10 A recent study demonstrated that 8-weeks of aerobic exercise can reduce liver fat, 
irrespective of exercise volume and intensity.11 Following 16 weeks of supervised exercise training in 
the present cohort, liver fat signiﬁcantly decreased and FMD increased by 2.9%, extrapolated from 
meta-analysis data to confer a CVD risk reduction of ~ 17%.12 Nevertheless, this improvement had 
disappeared 12 months after cessation of exercise supervision. 
To the authors’ knowledge, no study to date has undertaken longer-term follow-up of the exercise-
induced improvements in liver and vascular health following cessation of supervision. This study 
suggests that short-term exercise interventions have only short-term beneﬁts. 
In contrast, improvements in liver transaminases, liver fat and insulin resistance observed after a 6-
month hypocaloric diet with dietary counselling were maintained for 17–36 months after ending 
counselling, despite modest weight regain;13 however, this study did not examine the effects on CVD 
risk, the leading cause of mortality in NAFLD.2,14 In our study, changes in liver fat and FMD were 
strongly associated with changes in cardiorespiratory ﬁtness, suggesting that maintenance of 
exercise-induced improvements in cardiometabolic parameters depends upon sustained 
cardiorespiratory ﬁtness. It therefore appears that exercise and hypocaloric diet interventions 
modulate liver fat content across different time courses and perhaps via distinct mechanisms. 
Indeed, as little as 7 consecutive days of 60 min treadmill walking improves liver fat and increases 
insulin sensitivity in obese individuals with NAFLD.15 These data suggest that an increase in levels of 
physical activity with exercise training dynamically modulates liver fat, and that to achieve prolonged 
cardiometabolic beneﬁts, higher levels of ﬁtness must be maintained. Although the patients were 
counselled on the beneﬁts of exercise and encouraged to maintain their exercise training without 
further guidance, physical ﬁtness returned to preintervention level, suggesting that long-term 
supervision or alternative strategies of exercise provision are required. 
Limitations of this exploratory pilot study include a relatively small patient cohort, and a lack of 
intermediate post-intervention assessments and measures of insulin resistance. Follow-up 
assessments were based on patient choice and thus there is the possibility of cohort bias. 
In summary, although 16 weeks of supervised exercise effectively improves liver fat and endothelial 
function in NAFLD, the cardiometabolic beneﬁt of training is not sustained 12 months after ending 
supervision. To overcome the NAFLD epidemic we need an effective mechanism to promote long-
term maintenance fitness.  
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